Cargando…
Long Term Administration of Nivolumab for Metastatic Melanoma: A Case Report
The treatment of metastatic melanoma changed dramatically with the discovery of immune checkpoint inhibitors (ICIs). Patients face prolonged exposure to these agents, which can frequently generate a large spectrum of adverse reactions. It has been shown that a considerable number of patients treated...
Autores principales: | Oprea, Adela-Raluca, Benas, Arnaud, Havasi, Andrei, Gorzo, Alecsandra, Spinu, Stefan, Sur, Daniel, Burz, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329602/ https://www.ncbi.nlm.nih.gov/pubmed/35911362 http://dx.doi.org/10.7759/cureus.26359 |
Ejemplares similares
-
Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know
por: Gorzo, Alecsandra, et al.
Publicado: (2022) -
Trifluridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An efficacy and safety analysis
por: Sur, Daniel, et al.
Publicado: (2022) -
Time to Treatment With Nivolumab or Pembrolizumab for Patients With Advanced Melanoma in Everyday Practice
por: Ksienski, Doran, et al.
Publicado: (2021) -
Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade
por: Gorzo, Alecsandra, et al.
Publicado: (2022) -
Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma
por: Bari, Omar, et al.
Publicado: (2017)